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Abstract 
Background: Pilocytic Astrocytoma (PA) is a common type of brain tumor in the 
pediatric population. They have a fairly good prognosis. This study describes PAs in 
detail, with a focus on the demographic factors, presenting features, management 
and prognosis, and aims, to identify the negative outcome predictors in our 
population, which can affect the course of the disease. This article will add to the 
understanding of PAs from a third world perspective.
Methods: The Aga Khan University medical records (1995 – 2007) were reviewed, 
to study the clinical features, management, and outcome of patients (0 – 15 years) 
with Pilocytic Astrocytomas (PAs) in our population. After a thorough review of 
the medical records, all the PAs diagnosed on the basis of histopathology at our 
Pathology Laboratory, during this period, were included in the study.
Results: Twenty-two patients were included with a mean age of 9.25 years. 
Male-to-female ratio was 1 : 1. The most common presenting feature was a sign 
of increased intracranial pressure. The most common location was the cerebellum 
followed by the cerebrum. Fifteen patients underwent maximum surgical resection. 
Three had recurrence, despite no residual tumor. There were 10 Intensive Care 
Unit (ICU) admissions and one inpatient mortality. Fifteen patients followed up in 
the clinic: Eight had recurrence and four underwent repeat surgery (three showed 
clinical improvement). Hydrocephalus was a predictor of ICU admission. Solid 
consistency was found to be a marker of recurrence.
Conclusion: Pilocytic Astrocytomas are the most common pediatric brain tumors in 
our population, commonly located in the cerebellum. Complete resection is the best 
treatment option, but some tumors are aggressive and recurrence is not uncommon. 
The possible negative outcome predictors are age, source of admission, extent of 
resection, hydrocephalus, and solid consistency. 
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INTRODUCTION
Pilocytic Astrocytoma (PA) is a common type of brain 
tumor in the pediatric population. PAs comprise of 19.1% 
of all pediatric brain tumors in the age group 0 – 14 
years,[1] and have been reported to be the most common 
gliomas and cerebellar tumors in children.[6,8] They can 
involve the entire neuroaxis, but the cerebellum is the 
most common site of origin. Due to lack of population-
based studies, the actual incidence is not clear, but 
Burkhard et al.[7] reported an incidence of 4.8 per one 
million in the Canton of Zurich, Switzerland, while 
the Central Brain Tumor Registry of the United States 
(CBTRUS) reports it to be 2.9 per million in the US.[1] 
PAs are associated with a relatively benign clinical course. 
They have a fairly good prognosis with a five-year survival 
rate of 80 – 90%[12] and a 10-year survival rate of 81%,[13] 
depending on the tumor location and extent of resection. 
This may reflect the tumor’s slow growth and discrete 
nature, which allow complete surgical resection.[11] 
However, some of these tumors are more aggressive, have 
a higher rate of recurrence, and a poor prognosis. It is 
important to identify these patients correctly, as surgical 
treatment is usually curative.[3] In this article, we present 
our experience with PAs in the pediatric population. 
This study describes PAs in detail, with a focus on the 
demographic factors, presenting features, management 
and prognosis, and aims, to identify the negative outcome 
predictors in our population, which can affect the course 
of the disease. This article will add to the understanding 
of PAs from a third world perspective.
MATERIALS AND METHODS
This was a retrospective cross-sectional study. The Aga 
Khan University Hospital (AKUH) medical records 
were reviewed for a twelve-year period (1995 – 2007), 
after approval from the Ethical Review Committee of 
the AKUH, to identify pediatric brain tumor patients. 
The pediatric population was defined as patients aged 
below 15 years at the time of admission in our hospital. 
The patients were referred to our institution by various 
physicians in the community. As AKUH is one of the few 
centers in Pakistan operating on pediatric brain tumors, 
our referral catchment area was countrywide. After a 
thorough review of the medical records, all PAs diagnosed 
on the basis of histopathology at our Pathology Laboratory, 
during this period, were included in the study. Data was 
collected using a proforma on the following variables: 
age, gender, source of admission (Emergency Room or 
Consulting Clinic), presenting symptoms, radiological 
findings, tumor location, surgical management, adjuvant 
therapy (radiotherapy and chemotherapy), ICU 
admission, Inpatient mortality, neurological condition on 
discharge, duration of follow-up, neurological condition 
on follow-up in the clinic, recurrence, repeat surgery for 
recurrence, and late mortality. The association between 
the patient characteristics of age, gender, source of 
admission, hydrocephalus, and consistency, with the 
outcomes of ICU admission, recurrence, and repeat 
surgery were tested using Fisher’s exact tests. On account 
of the small sample sizes, multivariate modeling was 
not possible. P-values less than 0.05 were considered 
significant. All analyses were done using the SAS version 
9.2.
RESULTS
During the 12-year period of 1995 – 2007, 102 pediatric 
brain tumors were operated and 22 (21.6%) patients 
were diagnosed with Pilocytic Astrocytoma, based on the 
histopathology.
Demographics
The mean age of the patients was 9.25 years, with most 
of the patients presenting in the adolescent age group of 
10 to 15 years [Figure 1a]. Gender distribution was equal, 
with a male-to-female ratio of 1 : 1, but there was a male 
preponderance in the higher age group [Figure 1c]. Out 
of 22 patients, 18 (81.8%) were admitted from consulting 
clinics, while four (18.2%) were admitted through the 
Emergency Room. The duration of stay in the hospital 
ranged from two days to 46 days, with an average stay 
in the hospital of 12.4 days. The duration of stay in the 
hospital was longer in the younger age group [Figure 1d].
Presenting clinical and radiological features
Most of the patients (81.8%) presented with a Glasgow 
Coma Scale (GCS) of 15 / 15. Only one patient had 
a GCS of 3 and one had a GCS of 7. All the patients 
presented with more than one clinical sign, with signs of 
increased intracranial pressure (86.4%) being the most 
common, followed by focal neurological signs (52.9%) 
[Table 1].
Figure 1: Variation of (a) Distribution, (b) Location, (c) Gender, and 
(d) Duration of stay, with age
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Figure 2: Location of pilocytic astrocytomas
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Table 1: Presenting complaints of the patients
Presenting symptoms n = 22
Focal Neurological Signs
Motor Deficit in Limbs 7
Cranial Nerve Deficit 4
Seizures 5
Balance Difficulty 5
Symptoms of Raised ICP 19
Headache 17
Nausea 3
Vomiting 14
Drowsiness 3
A majority of our patients were diagnosed radiologically 
on the basis of magnetic resonance imaging (MRI). 
The MRI was used as a single diagnostic modality in 
12 (54.5%) patients, while computed tomography (CT) 
was used in three (13.6%) patients, but seven (31.8%) 
patients underwent both CT and MRI. Hydrocephalus 
was seen in nine (40.9%) cases. A cystic component was 
present in nine (40.9%) cases, while the remaining 13 
(59.1%) were of solid consistency. A total of six (27.3%) 
cases showed contrast enhancement.
Location of tumors
Pilocytic Astrocytomas showed a predilection for the 
cerebellum; 11 (50%) were found in the cerebellum, eight 
(36.4%) in the cerebrum, two (9.1%) in brainstem, and 
one (4.5%) in the basal ganglia [Figure 2]. The location 
of the tumor also varied with age; the cerebrum was the 
most common location in the 5 – 10 year age group, while 
the cerebellum was the most common location in the 
10 – 15 year age group [Figure 1b]. Among all pediatric 
brain tumors (n = 102), PAs were found to be the most 
common cerebral tumors (19.5%) and the second most 
common cerebellar tumors (33.3%), the most common 
being medulloblastoma (36.4%).
Histological features
Table 2 shows the histopathological details of all the 
tumors. Rosenthal fibers were present in 15 (68.2%) 
cases and microcysts were identified in 12 (54.5%), which 
were also associated with eosinophilic bodies. Fibrillary 
background was found in 17 (77.3%) of the tumors, but 
five (22.7%) were found to have a myxoid background. 
Other features were apparent only in a few cases: necrosis 
in three (13.6%), vascularity in five (22.7%), and mitoses 
in three (13.6%) of the cases.
Management
Surgical resection remained the mainstay of treatment, 
as all our patients underwent craniotomy, mostly for 
resection, with only two undergoing a biopsy. Out of 
these two patients, one died during the hospital stay and 
the other one did not show any clinical improvement 
(CI) on discharge.
Complete resection was attempted in 15 (68.2%) patients. 
Postoperative imaging was done in 10 of these patients; 
there was no residual tumor seen in seven of them, but 
three of the patients had a residual tumor. Even after no 
evidence of residual tumor in postoperative imaging, three 
patients had recurrence; one was given radiotherapy after 
repeat surgery, while one was treated with chemotherapy 
without any repeat surgery. The former showed clinical 
improvement, but the latter did not. Of the five (22.7%) 
patients who underwent partial resection, one was 
treated with postoperative radiotherapy, and one had late 
mortality, after 8.4 years, during the initial postoperative 
course of repeat craniotomy, due to recurrence of tumor. 
An extraventricular drain (EVD) was placed in seven 
Table 2: Different histological features of pilocytic 
astrocytomas
Histological features %
Fibrillary Background 77.8
Rosenthal Fibers 66.7
Microcysts 55.6
Eosinophilic Bodies 55.6
Cellular Pleomorphism 27.8
Vascularity 22.2
Myxoid Background 22.2
Calcification 11.1
Necrosis 11.1
Mitoses 11.1
patients before craniotomy, with two of them needing 
a ventriculoperitoneal shunt (VPS) later on. VPS alone 
was placed in three patients. Figure 3 shows how the 
extent of resection of the tumor affected the subsequent 
management and outcome of the patients.
Outcome
Ten (45%) patients were admitted in the Intensive 
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Figure 3:  Treatment pathway of 22 surgically operated Pilocytic Astrocytomas: Extent of resection, subsequent management, and outcome. 
CI: Clinical improvement, FUP: Follow-up
Care Unit (ICU) and one (4.5%) patient died during 
the hospital course. This patient underwent biopsy of a 
tumor in the cerebrum. Most of the patients, 20 (90.9%), 
had neurological improvement on discharge. Out of 
22, 15 (68.2%) patients came for follow-up visits in the 
clinic and 11 (73.3%) showed progressive neurological 
improvement. The follow-up time period ranged from 
three months to 12 years, with a mean follow-up period 
of 3.72 years [Figure 4]. Recurrence was observed in eight 
(53.3%) of these patients, of whom four underwent repeat 
surgery. The time of recurrence ranged from eight months 
to 8.4 years and the mean time period for recurrence was 
found to be 3.7 years. Patients who did not have repeat 
surgery showed no clinical improvement, while three of 
the four patients who underwent repeat surgery showed 
clinical improvement, and one patient died after repeat 
surgery due to status epilepticus.
Predictors of negative outcome 
A number of factors (e.g., age, source of admission, 
gender, location of tumor, cystic component, contrast 
enhancement, hydrocephalus, and extent of resection) 
were considered, which could affect the postoperative 
course, functional status, and prognosis of the patients 
[Table 3]. Inpatient mortality and late mortality, were 
both seen in the age group of 1 – < 5 years, although 
recurrence was more common in the older age groups. Out 
of the 10 ICU admissions, three (33%) were females (P = 
017). Tumor recurrence was higher in males (P = 0.019). 
Admission through the Emergency Room (ER) led to 
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Figure 4: Follow-up of 15 patients ranging from 0 – 12 years. CI: Clinical improvement, FUP: Follow-up
Table 3: Predictors of negative outcome (age, source of admission, solid consistency, and hydrocephalus) in patients 
with ICU admission, Inpatient mortality, recurrence, and late mortality
Consistency
Cystic
3
75%
1
100%
5
62.5%
3
60%
0
0%
Solid
1
25%
0
0%
3
37.5%
2
40%
1
100%
Hydrocephalus
No
3
75%
1
100%
3
37.5%
1
20%
0
0%
Yes
1
25%
0
0%
5
62.5%
4
80%
1
100%
Source of 
Admission
CC
1
25%
0
0%
7
87.5%
5
100%
1
0%
ER
3
75%
1
100%
1
12.5%
0
0%
0
0%
Gender
Female
3
75%
1
100%
4
50%
3
60%
0
0%
Male
1
25%
0
0%
4
50%
2
40%
1
100%
Age
10 – 15
2
50%
0
0%
3
37.5%
1
20%
0
0%
5- < 10
1
25%
0
0%
4
50%
3
60%
0
0%
1- < 5
1
25%
1
100%
1
12.5%
1
20%
1
100%
ICU Admission
Inpatient Mortality
Recurrence
Repeat Surgery
Late Mortality
three (30%) ICU admissions, but did not affect the long-
term clinical outcome. Hydrocephalus was found to be a 
negative outcome predictor in terms of ICU admission, 
repeat surgery, and late mortality [Tables 3 and 4]. 
The extent of resection was also a negative outcome 
predictor in terms of Inpatient mortality and late 
mortality [Figure 3]. The solid consistency of tumors led 
to a poor prognosis, as it was associated with a greater 
number of ICU admissions, recurrence of tumors, and 
repeat surgeries (60%) [Tables 3 and 4].
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Table 4: Associations of demographic and clinical characteristics with outcomes of interest
Variable Response N # with ICU 
admission 
(%)
P-value # with 
Recurrence 
(%)
P-value # with Repeat 
surgery  
(%)
P-value
Overall 19 10 (53) 8 (42) 4 (21)
Age < 5 5 3 (60) > 0.99 1 (20) 0.435 1 (20) 0.309
5- < 10 6 3 (50) 2 (33) 0 (0)
10 – 15 8 4 (50) 5 (63) 3 (38)
Gender Male 10 7 (70) 0.178 7 (70) 0.019 4 (40) 0.086
Female 9 3 (33) 1 (11) 0 (0)
Source of Admission ER 5 3 (60) > 0.99 4 (80) 0.110 2 (40) 0.272
Clinic 14 7 (50) 4 (29) 2 (14)
Hydrocephalus Yes 11 10 (91) < 0.001 7 (64) 0.058 4 (36) 0.103
No 8 0 (0) 1 (13) 0 (0)
Consistency Solid 6 4 (67) 0.628 6 (100) 0.001 2 (33) 0.557
Cystic 13 6 (46) 2 (15) 2 (15)
DISCUSSION
Pilocytic Astrocytomas were found to be the most 
common pediatric brain tumors (21.6%) in our study 
population, which was comparable to the CBTRUS,[1] 
which showed that the incidence of PAs was 19.1% in 
the 0 – 14 years age group, and Rickert and Paulus,[19] 
who observed that PAs comprised of 23.5% of their 
study population. However, some studies showed that 
prevalence could be as low as 5.5%, [7] although there 
was no evidence of increased incidence of PA in any 
racial or ethnic group.[18] The male-to-female ratio in 
our population was 1 : 1, which was comparable to 1.12 
according to Burkhard et al.[7] and the general trend of 
no gender predilection observed in PAs.[6] The mean age 
of 9.25 years observed in our study was similar to the 
mean age of 8 years noted by Krieger et al.[15] and 10.6 
years observed in a study by Malik et al.[16] Although PA 
was a slow growing tumor, four (18.4%) of the patients 
were admitted through ER. This was unusual and it had 
a significant impact on the prognosis of the patient. 
The most common presenting complaints were signs of 
increased intracranial pressure (ICP) (86.4%) and focal 
neurological deficits (50%), which were comparable to 
other studies.[2,3,9]
Pilocytic Astrocytomas could arise in various locations 
in the neuroaxis, such as, the optic nerve, optic chiasm, 
hypothalamus, cerebellum, brain stem, thalamus, 
basal ganglia, and cerebral hemispheres. In our study, 
they showed a predilection toward the posterior fossa, 
particularly the cerebellum (50%). Aarsen et al.[2] and 
Fernandez et al.[9] reported a similar trend, but their 
cases were also located in the optic chiasm and spinal 
cord. The MRI and CT scan showed a cystic component 
in 40.9% of the patients and contrast enhancement in 
20.3%. PAs appearing solid on the MRI were presumed 
to be more aggressive. Our study also showed differences 
in the outcome of solid and cystic PAs, but these were 
not statistically significant. Strong et al.[21] evaluated 
the radiological images of PAs with regard to tumor 
distribution, size, morphological appearance, calcification, 
and degree of contrast enhancement, in their study, but 
we were unable to distinguish tumors that would follow 
an aggressive course from the tumors that would behave 
in a more benign manner. Thus, they concluded that 
imaging features were unreliable in predicting clinical 
behavior. Maximum resection was attempted in 15 
patients; seven (46.7%) of them had no residual tumor, 
five (33.3%) had residual tumor, and three (20%) did 
not have any postoperative imaging. Studies showed 
that direct neurosurgical evaluation of the extent of 
resection was surprisingly unreliable, and postoperative, 
contrast-enhanced, cross-sectional imaging, preferably 
MRI, was essential for definitive assessment.[14,20,22] 
Complete resection led to a better outcome, with most 
of the patients showing clinical improvement, and there 
was no Inpatient or late mortality. This showed the 
curative potential of resection, with no identifiable tumor 
left behind, as shown by other studies.[7,9] However, 
three (42.9%) of the seven patients in our study showed 
recurrence, even though there was no evidence of a 
postoperative residual tumor on imaging. This could be 
correlated with the findings of Strong et al.,[21] which 
stated more than one-third of their patients with PAs 
followed an unusually aggressive course, with progression, 
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or a recurrent tumor identified despite concurrent 
treatment.
There exists a subset of patients who have an aggressive 
clinical course and require multiple resections or other 
therapies to control tumor growth.[22] The reason for 
the aggressive behavior of the PAs, compared with most 
other studies describing PA as a benign entity, is unclear. 
Patients with only a tumor biopsy done, did not show any 
clinical improvement and one had Inpatient mortality. 
Partial resection led to recurrence in two (40%) patients 
and late mortality in one (20%) patient. Adjuvant 
therapy in the form of chemo- and radiotherapy was not 
necessary in PAs that were completely resected.[9] Very 
few patients with recurrence or partially resected tumors 
underwent chemotherapy and radiotherapy in our study 
and did not show clinical improvement if not combined 
with repeat resection.. Impact on survival by these 
adjuvant modalities is still controversial[7] and careful 
patient selection must be done.
Out of the total, 15 patients came for follow-up in 
clinics. Only one late mortality was seen after 8.4 
years, although eight patients had recurrence, and four 
underwent repeat surgery. Those patients who underwent 
repeat surgery showed clinical improvement, while 
others did not. It was found in a study conducted, in 
2001, that repeat surgery for tumors located in the 
cerebral hemispheres or cerebellum resulted in gross total 
resection or near total resection in all cases and resulted 
in long periods of progression-free survival, without 
further adjuvant treatment.[5] The time of recurrence 
ranged from eight months to 8.4 years and the mean 
time period for recurrence was found to be 3.7 years, 
which was comparable to another study, which showed 
that recurrence occurs between one and eight years.[3]
Due to variations in the prognosis of all the patients, we 
tried to find out the predictors of negative outcomes. 
Previous studies have identified several risk factors for 
tumor recurrence / progression including, age, site, and 
extent of resection, although several of these remain 
controversial.[4,10,17]
Aarsen et al.[2] found that disabilities were more 
significant in the supratentorial as compared to the 
infratentorial PAs. Berger et al.[4] noted that the extent 
of resection was significantly related to the recurrence 
of tumor. A retrospective study of 80 cases of PAs 
concluded that some clinicopathological factors, such as, 
partial resection, optochiasmatic location, invasion of the 
surrounding structures, and the pilomyxoid variant, had 
a worse prognosis.[9] In our study population, age, gender, 
source of admission, hydrocephalus, solid consistency, 
and the extent of resection, were found to be poor 
prognostic factors, whereas, location of the tumor and 
contrast enhancement on imaging did not have any effect 
on the prognosis. Although these factors were suggestive 
of poor outcome, the statistical significance could not 
be determined, due to the small sample size. Therefore, 
further population-based studies should be conducted to 
validate the identified predictors of negative outcomes.
CONCLUSION
Pilocytic Astrocytomas are the most common pediatric 
brain tumors in our population and are most commonly 
located in the cerebellum. Complete surgical resection 
is the best treatment option for PAs. However, some 
tumors follow an aggressive course and recurrence is not 
uncommon. A second surgical resection after recurrence 
has a likelihood of better prognosis. The negative 
outcome predictors, according to our study, are age, 
source of admission, extent of resection, solid consistency, 
and hydrocephalus. As the number of cases in our study 
is small, there is a need to do a larger study, with more 
cases of PAs in the Pakistani population, to determine 
if there are any ethnic differences in the epidemiology, 
prognostic factors, and outcomes, as compared to other 
studies from different parts of the world.
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